Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 8 de 8
Filtrar
1.
Radiol Med ; 122(10): 723-730, 2017 Oct.
Artículo en Inglés | MEDLINE | ID: mdl-28540564

RESUMEN

This position paper, issued by ICBR/SIRM and GISMa, summarizes the evidence on DBT and provides recommendations for its use. In the screening setting, DBT in adjunct to digital mammography (DM) increased detection rate by 0.5-2.7‰ and decreased false positives by 0.8-3.6% compared to DM alone in observational and double-testing experimental studies. The reduction in recall rate could be less prominent in those screening programs which already have low recall rates with DM. The increase in radiation exposure associated with DM/DBT protocols has been solved by the introduction of synthetic mammograms (sDM) reconstructed from DBT datasets. Thus, whenever possible, sDM/DBT should be preferred to DM/DBT. However, before introducing DBT as a routine screening tool for average-risk women, we should wait for the results of randomized controlled trials and for a statistically significant and clinically relevant reduction in the interval cancer rate, hopefully associated with a reduction in the advanced cancer rate. Otherwise, a potential for overdiagnosis and overtreatment cannot be excluded. Studies exploring this issue are ongoing. Screening of women at intermediate risk should follow the same recommendations, with particular protocols for women with previous BC history. In high-risk women, if mammography is performed as an adjunct to MRI or in the case of MRI contraindications, sDM/DBT protocols are suggested. Evidence exists in favor of DBT usage in women with clinical symptoms/signs and asymptomatic women with screen-detected findings recalled for work-up. The possibility to perform needle biopsy or localization under DBT guidance should be offered when DBT-only findings need characterization or surgery.


Asunto(s)
Neoplasias de la Mama/diagnóstico por imagen , Mamografía , Detección Precoz del Cáncer , Medicina Basada en la Evidencia , Femenino , Humanos , Italia
2.
Radiol Med ; 121(12): 891-896, 2016 Dec.
Artículo en Inglés | MEDLINE | ID: mdl-27601142

RESUMEN

Women who were previously treated for breast cancer (BC) are an important particular subgroup of women at intermediate BC risk. Their breast follow-up should be planned taking in consideration a 1.0-1.5 % annual rate of loco-regional recurrences and new ipsilateral or contralateral BCs during 15-20 years, and be based on a regional/district invitation system. This activity should be carried out by a Department of Radiology integrating screening and diagnostics in the context of a Breast Unit. We recommend the adoption of protocols dedicated to women previously treated for BC, with a clear definition of responsibilities, methods for invitation, site(s) of visits, methods for clinical and radiological evaluation, follow-up duration, role and function of family doctors and specialists. These women will be invited to get a mammogram in dedicated sessions starting from the year after the end of treatment. The planned follow-up duration will be at least 10 years and will be defined on the basis of patient's age and preferences, taking into consideration organizational matters. Special agreements can be defined in the case of women who have their follow-up planned at other qualified centers. Dedicated screening sessions should include: evaluation of familial/personal history (if previously not done) for identifying high-risk conditions which could indicate a different screening strategy; immediate evaluation of mammograms by one or, when possible, two breast radiologists with possible addition of supplemental mammographic views, digital breast tomosynthesis, clinical breast examination, breast ultrasound; and prompt planning of possible further workup. Results of these screening sessions should be set apart from those of general female population screening and presented in dedicated reports. The following research issues are suggested: further risk stratification and effectiveness of follow-up protocols differentiated also for BC pathologic subtype and molecular classification, and evaluation of different models of survivorship care, also in terms of cost-effectiveness.


Asunto(s)
Neoplasias de la Mama/diagnóstico por imagen , Neoplasias de la Mama/patología , Continuidad de la Atención al Paciente , Recurrencia Local de Neoplasia/diagnóstico por imagen , Recurrencia Local de Neoplasia/patología , Neoplasias de la Mama/terapia , Consenso , Femenino , Humanos , Italia , Mamografía , Tamizaje Masivo , Medición de Riesgo , Sociedades Médicas
4.
Ann Ist Super Sanita ; 56(4): 470-477, 2020.
Artículo en Inglés | MEDLINE | ID: mdl-33346173

RESUMEN

INTRODUCTION: In Italy, minor migrants represent 21.8% of the non-EU citizens. The care of minor migrants might be challenging as this population is characterized by higher vulnerability and special needs. The study aim was to describe the perceptions on the provision of care, the bio-psycho-social needs of migrant children and the professional training needs. METHODS: The study is qualitative descriptive. In May 2019 three focus group, involving health and social professionals, cultural mediators and NGOs operators, were organized. RESULTS: The study explored different areas of the provision of care to minor migrants including bio-psycho-social needs, care provision, barriers to care and professionals' training needs. DISCUSSION AND CONCLUSIONS: The provision of care should consider the specific migration journey and narrative. In some cases healthcare is fragmented, generating obstacles to access especially in minors with lower levels of health literacy. Training plays a key role in the development of cultural competence.


Asunto(s)
Actitud Frente a la Salud , Personal de Salud/educación , Trabajadores Sociales/educación , Migrantes , Niño , Personal de Salud/psicología , Humanos , Italia , Evaluación de Necesidades , Investigación Cualitativa , Autoinforme , Trabajadores Sociales/psicología
5.
BMJ Paediatr Open ; 5(1): e001191, 2021.
Artículo en Inglés | MEDLINE | ID: mdl-34493988
6.
Health Policy ; 63(2): 179-86, 2003 Feb.
Artículo en Inglés | MEDLINE | ID: mdl-12543530

RESUMEN

The media can play an important role in influencing both the demand and supply of medical treatments, regardless of evidence of effectiveness. This can be highlighted by recent experiences in Italy following publicity for a new unproven treatment in Italy, which it was claimed was highly successful in treating a wide range of cancers. The media role in influencing both health authorities to fund large scale trials of the intervention and patients awareness and expectations of therapy are discussed. The changes in Italian media over the last 20 years have seen a reduction in the numbers of specialist medical journals, with increased emphasis placed on sensationalism rather than accuracy. The media though has the potential to play in future an important strategic role in disseminating accurate information on issues pertaining to health.


Asunto(s)
Política de Salud , Difusión de la Información , Periodismo Médico/normas , Medios de Comunicación de Masas/normas , Neoplasias/terapia , Opinión Pública , Terapias en Investigación , Medicina Basada en la Evidencia , Necesidades y Demandas de Servicios de Salud , Humanos , Italia , Medios de Comunicación de Masas/economía , Estudios de Casos Organizacionales , Comunicación Persuasiva , Relaciones Médico-Paciente , Evaluación de la Tecnología Biomédica/economía , Terapias en Investigación/economía , Terapias en Investigación/psicología , Terapias en Investigación/normas
8.
Epidemiol Prev ; 27(3): 139, 2003.
Artículo en Italiano | MEDLINE | ID: mdl-12958730
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA